At CAP 2024, cutting-edge technology in digital pathology was introduced—MUSE Microscopy, which brings direct-to-digital imaging from fresh tissue to pathology workflows. In this panel discussion, Dr. Rao, Dr. Jeff Edwards, and CEO Matt Nunez explore the impact of SmartPath, a slide-free imaging device, and its potential to transform pathology.

Topics Covered:

✅ How SmartPath eliminates the need for traditional slide preparation.

✅ The benefits of direct-to-digital pathology in human and veterinary medicine.

✅ How AI integration enhances pathology workflows.

✅ The impact of this innovation on diagnostics, molecular studies, and efficiency.

✅ Scaling capabilities and the future of digital pathology.

This session offers a deep dive into next-generation pathology technology, covering workflow improvements, AI applications, and clinical relevance. Whether you’re a pathologist, researcher, or digital pathology enthusiast, this discussion will give you insights into how direct-to-digital pathology is shaping the future.

✨ Key Highlights

• MUSE Microscopy’s direct-to-digital tissue imaging technology and its impact on pathology.
• How AI is integrated into digital pathology imaging.
• The role of SmartPath in veterinary and human pathology.
• Scaling direct-to-digital imaging for clinical and research applications.
• Advantages of real-time pathology imaging over traditional workflows